Browse by Title

Type here to filter the list

#
1: Annual Cost Savings with the Implementation of Estrogen-receptor-only Testing on DCIS Specimens

Jaclyn Gellings, MD – Medical College of Wisconsin ### 1530232###Abstract Presenter###Resident Physician###Medical College of Wisconsin###
Abstract Presenter: Jaclyn Gellings, MD – Medical College of Wisconsin
1: Q&A

Jaclyn Gellings, MD – Medical College of Wisconsin ### 1530232###Abstract Presenter###Resident Physician###Medical College of Wisconsin###
Abstract Presenter: Jaclyn Gellings, MD – Medical College of Wisconsin
10: KEYNOTE-522: Neoadjuvant Pembrolizumab + Chemotherapy vs Placebo + Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early-stage Triple Negative Breast Cancer

Heather McArthur, MD – University of Texas Southwestern Medical Center ### 1530225###Abstract Presenter###Clinical Director of Breast Oncology and Komen Distinguished Chair in Clinical Breast Cancer Research###University of Texas Southwestern Medical Center###
Abstract Presenter: Heather McArthur, MD – University of Texas Southwestern Medical Center
10: Q&A

Heather McArthur, MD – University of Texas Southwestern Medical Center ### 1530225###Abstract Presenter###Clinical Director of Breast Oncology and Komen Distinguished Chair in Clinical Breast Cancer Research###University of Texas Southwestern Medical Center###
Abstract Presenter: Heather McArthur, MD – University of Texas Southwestern Medical Center
11: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: effects of Age and Tumor ki67

Judy C. Boughey, MD, FACS – Mayo Clinic ### 937371###Abstract Presenter###Professor of Surgery, W.H. Odell Professor in Individualized Medicine, Chair-Division of Breast and Melanoma Surgical Oncology, Department of Surgery###Mayo Clinic###
Abstract Presenter: Judy C. Boughey, MD, FACS – Mayo Clinic
11: Q&A

Judy C. Boughey, MD, FACS – Mayo Clinic ### 937371###Abstract Presenter###Professor of Surgery, W.H. Odell Professor in Individualized Medicine, Chair-Division of Breast and Melanoma Surgical Oncology, Department of Surgery###Mayo Clinic###
Abstract Presenter: Judy C. Boughey, MD, FACS – Mayo Clinic
12: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly: Are We Accomplishing Our Treatment Goals?

Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center ### 1186261###Abstract Presenter###Breast Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center
12: Q&A

Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center ### 1186261###Abstract Presenter###Breast Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center
13: Nodal Positivity in Early Stage Triple Negative Breast Cancer (TNBC): Implications for Preoperative Immunotherapy

Elizabeth A. Mittendorf, MD PhD – Brigham and Womens Hospital/Harvard Medical School ### 1530213###Abstract Presenter###Rob and Karen Hale Distinguished Chair in Surgical Oncology###Brigham and Womens Hospital/Harvard Medical School###
Abstract Presenter: Elizabeth A. Mittendorf, MD PhD – Brigham and Womens Hospital/Harvard Medical School
13: Q&A

Elizabeth A. Mittendorf, MD PhD – Brigham and Womens Hospital/Harvard Medical School ### 1530213###Abstract Presenter###Rob and Karen Hale Distinguished Chair in Surgical Oncology###Brigham and Womens Hospital/Harvard Medical School###
Abstract Presenter: Elizabeth A. Mittendorf, MD PhD – Brigham and Womens Hospital/Harvard Medical School
14: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-negative Patients Having Upfront Mastectomy

Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center ### 1186261###Abstract Presenter###Breast Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center
14: Q&A

Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center ### 1186261###Abstract Presenter###Breast Surgical Oncology Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Austin D. Williams, MD MSEd – Memorial Sloan Kettering Cancer Center
15: Oncotypedx Testing Does Not Appear to Benefit Patients with Grade 1, Progesterone Receptor Positive Breast Cancers: A Tailorx Validated Study

Udai S. Sibia, MD MBA – Anne Arundel Medical Center ### 1186222###Abstract Presenter###General Surgery Resident###Anne Arundel Medical Center###
Abstract Presenter: Udai S. Sibia, MD MBA – Anne Arundel Medical Center
15: Q&A

Udai S. Sibia, MD MBA – Anne Arundel Medical Center ### 1186222###Abstract Presenter###General Surgery Resident###Anne Arundel Medical Center###
Abstract Presenter: Udai S. Sibia, MD MBA – Anne Arundel Medical Center
16: Preliminary Results of a Phase ib/2 Window of Opportunity Clinical Trial (NCT04454528) Assessing the Effects of Preoperative (preop) Pembrolizumab +/- radiation in Early-stage Breast Cancer (eBC)

Julia Tchou, MD PhD – University of Pennsylvannia ### 1530212###Abstract Presenter###Professor###University of Pennsylvannia###
Abstract Presenter: Julia Tchou, MD PhD – University of Pennsylvannia
16: Q&A

Julia Tchou, MD PhD – University of Pennsylvannia ### 1530212###Abstract Presenter###Professor###University of Pennsylvannia###
Abstract Presenter: Julia Tchou, MD PhD – University of Pennsylvannia
17: Prospective Pilot Study of First in Human Use of Single Port Robotic Platform in Nipple Sparing Mastectomy

Deborah E. Farr, MD – UT Southwestern Medical Center ### 1530304###Abstract Presenter###Associate Professor###UT Southwestern Medical Center###
Abstract Presenter: Deborah E. Farr, MD – UT Southwestern Medical Center
17: Q&A

Deborah E. Farr, MD – UT Southwestern Medical Center ### 1530304###Abstract Presenter###Associate Professor###UT Southwestern Medical Center###
Abstract Presenter: Deborah E. Farr, MD – UT Southwestern Medical Center
18: Q&A

Olga Kantor, MD MS – Brigham and Women's Hospital ### 1186247###Abstract Presenter###Breast Surgeon###Brigham and Women's Hospital###
Abstract Presenter: Olga Kantor, MD MS – Brigham and Women's Hospital
18: Sentinel Lymph Node Biopsy Alone Is Adequate for Chemotherapy Decisions in Postmenopausal Early-stage Hormone-receptor Positive, HER2 Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes

Olga Kantor, MD MS – Brigham and Women's Hospital ### 1186247###Abstract Presenter###Breast Surgeon###Brigham and Women's Hospital###
Abstract Presenter: Olga Kantor, MD MS – Brigham and Women's Hospital
19: Q&A

Stacy B. Sanders, MD, MS, MHA – Mayo Clinic ### 1530323###Abstract Presenter###Surgical Breast Oncology Fellow###Mayo Clinic###
Abstract Presenter: Stacy B. Sanders, MD, MS, MHA – Mayo Clinic
19: Sentinel Lymph Node Metastasis Size and Tumor Biology Predict Non-sentinel Lymph Node Involvement After Neoadjuvant Chemotherapy for Breast Cancer

Stacy B. Sanders, MD, MS, MHA – Mayo Clinic ### 1530323###Abstract Presenter###Surgical Breast Oncology Fellow###Mayo Clinic###
Abstract Presenter: Stacy B. Sanders, MD, MS, MHA – Mayo Clinic
2: Association Between Overall Survival and Chemotherapy Receipt According to Age and 21-gene Recurrence Score

Amanda L. Nash, MD – Duke University School of Medicine ### 1530329###Abstract Presenter###Resident###Duke University School of Medicine###
Abstract Presenter: Amanda L. Nash, MD – Duke University School of Medicine
2: Q&A

Amanda L. Nash, MD – Duke University School of Medicine ### 1530329###Abstract Presenter###Resident###Duke University School of Medicine###
Abstract Presenter: Amanda L. Nash, MD – Duke University School of Medicine
20: Q&A

Shelley Hwang, MD MPH – Duke University ### 937373###Abstract Presenter###Vice Chair of Research, Chief of Breast Surgical Oncology###Duke University###
Abstract Presenter: Shelley Hwang, MD MPH – Duke University
20: The Clinical Impact of Intraoperative Margin Assessment in Breast Cancer Surgery
Using A Novel Pegulicianine Fluorescence Guided Surgery System: A Prospective Single Arm Study

Shelley Hwang, MD MPH – Duke University ### 937373###Abstract Presenter###Vice Chair of Research, Chief of Breast Surgical Oncology###Duke University###
Abstract Presenter: Shelley Hwang, MD MPH – Duke University
21: Dynamics of Circulating Tumor DNA After Resection of Colorectal Cancer : GALAXY Study in Circulate-japan

Eiji Oki, MD, PhD, FACS – Kyushu University ### 1530204###Abstract Presenter###Associate Professsor###Kyushu University###
Abstract Presenter: Eiji Oki, MD, PhD, FACS – Kyushu University
21: Q&A

Eiji Oki, MD, PhD, FACS – Kyushu University ### 1530204###Abstract Presenter###Associate Professsor###Kyushu University###
Abstract Presenter: Eiji Oki, MD, PhD, FACS – Kyushu University
22: Patterns of Differential Gene Expression May Provide Potential Biomarkers for Anal Cancer Progression

Leah E. Hendrick, MD, MS – UTHSC Department of Surgery ### 970031###Abstract Presenter###Resident###UTHSC Department of Surgery###
Abstract Presenter: Leah E. Hendrick, MD, MS – UTHSC Department of Surgery
22: Q&A

Leah E. Hendrick, MD, MS – UTHSC Department of Surgery ### 970031###Abstract Presenter###Resident###UTHSC Department of Surgery###
Abstract Presenter: Leah E. Hendrick, MD, MS – UTHSC Department of Surgery
23: PERIOP-01: A Randomized Controlled Trial of Extended Perioperative Tinzaparin to Improve Disease-free Survival in Patients with Resectable Colorectal Cancer

Rebecca C. Auer, MD, MSc, FRCSC, FACS – Ottawa Hospital Research Institute ### 969495###Abstract Presenter###Scientific Director, Cancer Therapeutics Program###Ottawa Hospital Research Institute###
Abstract Presenter: Rebecca C. Auer, MD, MSc, FRCSC, FACS – Ottawa Hospital Research Institute
23: Q&A

Rebecca C. Auer, MD, MSc, FRCSC, FACS – Ottawa Hospital Research Institute ### 969495###Abstract Presenter###Scientific Director, Cancer Therapeutics Program###Ottawa Hospital Research Institute###
Abstract Presenter: Rebecca C. Auer, MD, MSc, FRCSC, FACS – Ottawa Hospital Research Institute
24: Q&A

Ankur Tiwari, MBBS – University of Texas Health Science Center San Antonio ### 1530300###Abstract Presenter###Resident###University of Texas Health Science Center San Antonio###
Abstract Presenter: Ankur Tiwari, MBBS – University of Texas Health Science Center San Antonio
24: Results of a Phase I Trial of Neoadjuvant Pallov-cc Vaccine in Colorectal Cancer

Ankur Tiwari, MBBS – University of Texas Health Science Center San Antonio ### 1530300###Abstract Presenter###Resident###University of Texas Health Science Center San Antonio###
Abstract Presenter: Ankur Tiwari, MBBS – University of Texas Health Science Center San Antonio
25: Q&A

Rami James N. Aoun, MD, MPH – Department of Surgery, The Ohio State Wexner Medical Center ### 1530312###Abstract Presenter###Resident###Department of Surgery, The Ohio State Wexner Medical Center###
Abstract Presenter: Rami James N. Aoun, MD, MPH – Department of Surgery, The Ohio State Wexner Medical Center
25: Transcriptomic Profiles Predict Rectal Cancer Response to Radiation

Rami James N. Aoun, MD, MPH – Department of Surgery, The Ohio State Wexner Medical Center ### 1530312###Abstract Presenter###Resident###Department of Surgery, The Ohio State Wexner Medical Center###
Abstract Presenter: Rami James N. Aoun, MD, MPH – Department of Surgery, The Ohio State Wexner Medical Center
26: Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?

Luis C. Borbon, MD – University of Iowa Hospitals and Clinics ### 1530273###Abstract Presenter###General Surgery Resident###University of Iowa Hospitals and Clinics###
Abstract Presenter: Luis C. Borbon, MD – University of Iowa Hospitals and Clinics
26: Q&A

Luis C. Borbon, MD – University of Iowa Hospitals and Clinics ### 1530273###Abstract Presenter###General Surgery Resident###University of Iowa Hospitals and Clinics###
Abstract Presenter: Luis C. Borbon, MD – University of Iowa Hospitals and Clinics
27: Long-term Outcomes of Patients with Multiple Endocrine Neoplasia Type 1 and Pancreatic Neuroendocrine Tumors

Jason B. Liu, MD, MS – University of Pittsburgh Medical Center ### 1530223###Abstract Presenter###Fellow###University of Pittsburgh Medical Center###
Abstract Presenter: Jason B. Liu, MD, MS – University of Pittsburgh Medical Center
27: Q&A

Jason B. Liu, MD, MS – University of Pittsburgh Medical Center ### 1530223###Abstract Presenter###Fellow###University of Pittsburgh Medical Center###
Abstract Presenter: Jason B. Liu, MD, MS – University of Pittsburgh Medical Center
28: Q&A

Aradhya Nigam, MD – MSKCC ### 1530265###Abstract Presenter###Research Fellow###MSKCC###
Abstract Presenter: Aradhya Nigam, MD – MSKCC
28: Tumor Grade Predicts Calcitonin Doubling Times After Curative Resection of Medullary Thyroid Cancer

Aradhya Nigam, MD – MSKCC ### 1530265###Abstract Presenter###Research Fellow###MSKCC###
Abstract Presenter: Aradhya Nigam, MD – MSKCC
29: An Immune-inflamed Tumor Environment as Defined by CD8 Score Is Associated with Favorable Oncologic Outcomes in Hepatocellular Carcinoma Independent of Tumor Mutational Burden

Eihab N. Abdelfatah, MD – Roswell Park Comprehensive Cancer Center ### 1186068###Abstract Presenter###Fellow - Complex General Surgical Oncology###Roswell Park Comprehensive Cancer Center###
Abstract Presenter: Eihab N. Abdelfatah, MD – Roswell Park Comprehensive Cancer Center
29: Q&A

Eihab N. Abdelfatah, MD – Roswell Park Comprehensive Cancer Center ### 1186068###Abstract Presenter###Fellow - Complex General Surgical Oncology###Roswell Park Comprehensive Cancer Center###
Abstract Presenter: Eihab N. Abdelfatah, MD – Roswell Park Comprehensive Cancer Center
3: Association of hydroxy-delta-5-steroid Dehydrogenase, 3 Beta- and Steroid Delta-isomerase 1 Genetic Inheritance and Distant Metastasis in Post-menopausal Breast Cancer

Meghan R. Flanagan, MD, MPH, FACS – University of Washington ### 1530237###Abstract Presenter###Assistant Professor###University of Washington###
Abstract Presenter: Meghan R. Flanagan, MD, MPH, FACS – University of Washington
3: Q&A

Meghan R. Flanagan, MD, MPH, FACS – University of Washington ### 1530237###Abstract Presenter###Assistant Professor###University of Washington###
Abstract Presenter: Meghan R. Flanagan, MD, MPH, FACS – University of Washington
30: Biliary Complications During Neoadjuvant Therapy for Pancreatic Cancer

Sam Thalji, MD – Medical College of Wisconsin ### 1184660###Abstract Presenter###Resident###Medical College of Wisconsin###
Abstract Presenter: Sam Thalji, MD – Medical College of Wisconsin
30: Q&A

Sam Thalji, MD – Medical College of Wisconsin ### 1184660###Abstract Presenter###Resident###Medical College of Wisconsin###
Abstract Presenter: Sam Thalji, MD – Medical College of Wisconsin
31: Combination Therapy with PXS-5505 Reduces Myeloid Suppression and Improves Overall Survival in Murine Cholangiocarcinoma

Paul R. Burchard, MD – University of Rochester Medical Center ### 1184658###Abstract Presenter###General Surgery Resident###University of Rochester Medical Center###
Abstract Presenter: Paul R. Burchard, MD – University of Rochester Medical Center
31: Q&A

Paul R. Burchard, MD – University of Rochester Medical Center ### 1184658###Abstract Presenter###General Surgery Resident###University of Rochester Medical Center###
Abstract Presenter: Paul R. Burchard, MD – University of Rochester Medical Center
32: Conditional Survival After Hepatectomy for Colorectal Liver Metastasis: Results from the Colorectal Liver Operative Metastasis International Collaborative

Cristian D. Valenzuela, MD – Wake Forest Baptist Medical Center ### 1186093###Abstract Presenter###Clinical Fellow###Wake Forest Baptist Medical Center###
Abstract Presenter: Cristian D. Valenzuela, MD – Wake Forest Baptist Medical Center
32: Q&A

Cristian D. Valenzuela, MD – Wake Forest Baptist Medical Center ### 1186093###Abstract Presenter###Clinical Fellow###Wake Forest Baptist Medical Center###
Abstract Presenter: Cristian D. Valenzuela, MD – Wake Forest Baptist Medical Center
33: Fluorescence-guided Surgery and Adjuvant Photoimmunotherapy Using a Single Fluorescent Antibody Reduces the Frequency of Metastatic Recurrence in an Orthotopic Nude Mouse Model of Pancreatic Cancer

Michael A. Turner, MD – University of California, San Diego ### 1184696###Abstract Presenter###Surgery resident###University of California, San Diego###
Abstract Presenter: Michael A. Turner, MD – University of California, San Diego
33: Q&A

Michael A. Turner, MD – University of California, San Diego ### 1184696###Abstract Presenter###Surgery resident###University of California, San Diego###
Abstract Presenter: Michael A. Turner, MD – University of California, San Diego
34: Impact of Neoadjuvant Treatment on Psychosocial Wellbeing in Patients with Pancreatic Cancer

Erin P. Ward, MD – Medical College of WIsconsin ### 1530234###Abstract Presenter###Fellow###Medical College of WIsconsin###
Abstract Presenter: Erin P. Ward, MD – Medical College of WIsconsin
34: Q&A

Erin P. Ward, MD – Medical College of WIsconsin ### 1530234###Abstract Presenter###Fellow###Medical College of WIsconsin###
Abstract Presenter: Erin P. Ward, MD – Medical College of WIsconsin
35: Machine Learning Can Predict Recurrence Patterns After Liver Transplantation in Hepatocellular Carcinoma Patients: Analysis from the US Multicenter HCC Transplant Consortium

Raja R. Narayan, MD MPH – Stanford University ### 1530276###Abstract Presenter###Surgery Resident###Stanford University###
Abstract Presenter: Raja R. Narayan, MD MPH – Stanford University
35: Q&A

Raja R. Narayan, MD MPH – Stanford University ### 1530276###Abstract Presenter###Surgery Resident###Stanford University###
Abstract Presenter: Raja R. Narayan, MD MPH – Stanford University
36: Mdsc-derived TNF Is a Novel Regulator of T-cell Dysfunction in Pancreatic Cancer

Anna Bianchi, MS – University of Miami Miller School of Medicine, Department of Surgery ### 1184669###Abstract Presenter###PhD Student###University of Miami Miller School of Medicine, Department of Surgery###
Abstract Presenter: Anna Bianchi, MS – University of Miami Miller School of Medicine, Department of Surgery
36: Q&A

Anna Bianchi, MS – University of Miami Miller School of Medicine, Department of Surgery ### 1184669###Abstract Presenter###PhD Student###University of Miami Miller School of Medicine, Department of Surgery###
Abstract Presenter: Anna Bianchi, MS – University of Miami Miller School of Medicine, Department of Surgery
37: Modulating the Gut Microbiome Stimulates Anti-tumor Immunity in Cigarette Smoking-driven Cancer Progression

vikas Dudeja, MD, FACS – University of Alabama ### 1048231###Abstract Presenter###Associate Professor of Surgery###University of Alabama###
Abstract Presenter: vikas Dudeja, MD, FACS – University of Alabama
37: Q&A

vikas Dudeja, MD, FACS – University of Alabama ### 1048231###Abstract Presenter###Associate Professor of Surgery###University of Alabama###
Abstract Presenter: vikas Dudeja, MD, FACS – University of Alabama
38: Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature

Austin M. Eckhoff, MD – Duke University ### 918099###Abstract Presenter###General Surgery Resident###Duke University###
Abstract Presenter: Austin M. Eckhoff, MD – Duke University
38: Q&A

Austin M. Eckhoff, MD – Duke University ### 918099###Abstract Presenter###General Surgery Resident###Duke University###
Abstract Presenter: Austin M. Eckhoff, MD – Duke University
39: Multi-omic Characterization Reveals a Distinct Molecular Landscape in Young-onset Pancreatic Cancer

Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami School of Medicine, Sylvester Comprehensive Cancer Center ### 1530239###Abstract Presenter###T32 Surgical Oncology Research Fellow###University of Miami School of Medicine, Sylvester Comprehensive Cancer Center###
Abstract Presenter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami School of Medicine, Sylvester Comprehensive Cancer Center
39: Q&A

Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami School of Medicine, Sylvester Comprehensive Cancer Center ### 1530239###Abstract Presenter###T32 Surgical Oncology Research Fellow###University of Miami School of Medicine, Sylvester Comprehensive Cancer Center###
Abstract Presenter: Ifeanyichukwu Ogobuiro, MD, MHS – University of Miami School of Medicine, Sylvester Comprehensive Cancer Center
4: Axillary Staging Is Not Justified in Postmenopausal Clinically Node Negative Women Based on Nodal Disease Burden

Minna K. Lee, MD – Memorial Sloan Kettering Cancer Center ### 1530221###Abstract Presenter###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Minna K. Lee, MD – Memorial Sloan Kettering Cancer Center
4: Q&A

Minna K. Lee, MD – Memorial Sloan Kettering Cancer Center ### 1530221###Abstract Presenter###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Minna K. Lee, MD – Memorial Sloan Kettering Cancer Center
40: Preoperative Exercise Attenuates the Progression of Liver Metastases After Surgical Stress by Altering the Immune Environment

Amblessed Onuma, MD MS – The Ohio State University Wexner Medical Center ### 1530243###Abstract Presenter###Resident###The Ohio State University Wexner Medical Center###
Abstract Presenter: Amblessed Onuma, MD MS – The Ohio State University Wexner Medical Center
40: Q&A

Amblessed Onuma, MD MS – The Ohio State University Wexner Medical Center ### 1530243###Abstract Presenter###Resident###The Ohio State University Wexner Medical Center###
Abstract Presenter: Amblessed Onuma, MD MS – The Ohio State University Wexner Medical Center
41: Q&A

Chris Javadi, MD, PhD – Stanford ### 1530294###Abstract Presenter###Fellow###Stanford###
Abstract Presenter: Chris Javadi, MD, PhD – Stanford
41: Radiographic, Biochemical, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which Is Best?

Chris Javadi, MD, PhD – Stanford ### 1530294###Abstract Presenter###Fellow###Stanford###
Abstract Presenter: Chris Javadi, MD, PhD – Stanford
42: Q&A

Brett Ecker, MD – MSKCC ### 1530209###Abstract Presenter###Clinical fellow###MSKCC###
Abstract Presenter: Brett Ecker, MD – MSKCC
42: Recurrence-free Survival versus Overall Survival as a Primary End Point for Resectable Colorectal Liver Metastasis Studies: Analysis of 2,983 Curative-intent Hepatectomies

Brett Ecker, MD – MSKCC ### 1530209###Abstract Presenter###Clinical fellow###MSKCC###
Abstract Presenter: Brett Ecker, MD – MSKCC
43: Q&A

Alexandra Gangi, MD – Cedars Sinai Medical Center ### 937468###Abstract Presenter###Assistant Professor, Director of Gastrointestinal Tumor Program###Cedars Sinai Medical Center###
Abstract Presenter: Alexandra Gangi, MD – Cedars Sinai Medical Center
43: S-adenosylmethionine Protects Against Folfox-induced Liver Injury

Alexandra Gangi, MD – Cedars Sinai Medical Center ### 937468###Abstract Presenter###Assistant Professor, Director of Gastrointestinal Tumor Program###Cedars Sinai Medical Center###
Abstract Presenter: Alexandra Gangi, MD – Cedars Sinai Medical Center
44: Q&A

Matthew K. Iyer, MD/PhD – Duke University Medical Center ### 1530293###Abstract Presenter###Fellow, Complex General Surgical Oncology###Duke University Medical Center###
Abstract Presenter: Matthew K. Iyer, MD/PhD – Duke University Medical Center
44: Spatial Transcriptome Profiling of Intraductal Papillary Mucinous Neoplasms Nominates Novel Cyst Fluid Biomarkers of High-grade Dysplasia

Matthew K. Iyer, MD/PhD – Duke University Medical Center ### 1530293###Abstract Presenter###Fellow, Complex General Surgical Oncology###Duke University Medical Center###
Abstract Presenter: Matthew K. Iyer, MD/PhD – Duke University Medical Center
45: Q&A

Joseph Kearney, MD – University of North Carolina ### 1530263###Abstract Presenter###Surgical Resident###University of North Carolina###
Abstract Presenter: Joseph Kearney, MD – University of North Carolina
45: Tumor Stroma Crosstalk in Pancreatic Ductal Adenocarcinoma Is Molecular Subtype Dependent

Joseph Kearney, MD – University of North Carolina ### 1530263###Abstract Presenter###Surgical Resident###University of North Carolina###
Abstract Presenter: Joseph Kearney, MD – University of North Carolina
46: C-terminal hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma

Katie K. Spielbauer, MD – Michigan Medicine ### 1201150###Abstract Presenter###Resident ###Michigan Medicine###
Abstract Presenter: Katie K. Spielbauer, MD – Michigan Medicine
46: Q&A

Katie K. Spielbauer, MD – Michigan Medicine ### 1201150###Abstract Presenter###Resident ###Michigan Medicine###
Abstract Presenter: Katie K. Spielbauer, MD – Michigan Medicine
47: Neoadjuvant Systemic Therapy for Merkel Cell Carcinoma: A Tertiary Referral Center Experience

Russell G. Witt, MD, M.A.S. – University of Texas MD Anderson Cancer Center ### 1534603###Abstract Presenter###Complex General Surgical Oncology Fellow###University of Texas MD Anderson Cancer Center###
Abstract Presenter: Russell G. Witt, MD, M.A.S. – University of Texas MD Anderson Cancer Center
47: Q&A

Russell G. Witt, MD, M.A.S. – University of Texas MD Anderson Cancer Center ### 1534603###Abstract Presenter###Complex General Surgical Oncology Fellow###University of Texas MD Anderson Cancer Center###
Abstract Presenter: Russell G. Witt, MD, M.A.S. – University of Texas MD Anderson Cancer Center
48: Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-positive Sentinel Node Melanoma: The Role of the First Post-operative Ultrasound

Jennifer Keller, MD – Saint John's Providence Cancer Institute ### 1530316###Abstract Presenter###Complex General Surgical Oncology Fellow###Saint John's Providence Cancer Institute###
Abstract Presenter: Jennifer Keller, MD – Saint John's Providence Cancer Institute
48: Q&A

Jennifer Keller, MD – Saint John's Providence Cancer Institute ### 1530316###Abstract Presenter###Complex General Surgical Oncology Fellow###Saint John's Providence Cancer Institute###
Abstract Presenter: Jennifer Keller, MD – Saint John's Providence Cancer Institute
49: Q&A

Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital ### 944415###Abstract Presenter###Professor of Plastic and Reconstructive Surgery###Norfolk & Norwich University Hospital###
Abstract Presenter: Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital
49: Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients

Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital ### 944415###Abstract Presenter###Professor of Plastic and Reconstructive Surgery###Norfolk & Norwich University Hospital###
Abstract Presenter: Marc D. Moncrieff, MD FRCS(Plast.) – Norfolk & Norwich University Hospital
4D CT for Localization

Jeffrey Pelton, MD, MS, MBA, FACS – Mary Washington Health Care ### 1502387###HUB Presenter###Attending Surgeon###Mary Washington Health Care###
HUB Presenter: Jeffrey Pelton, MD, MS, MBA, FACS – Mary Washington Health Care
5: B-cell Produced Antibodies May Activate Complement During Immune Checkpoint Blockade in a Murine Model of Triple Negative Breast Cancer

Xavier L. Baldwin, MD – University of North Carolina Hospitals ### 1186260###Abstract Presenter###Resident###University of North Carolina Hospitals###
Abstract Presenter: Xavier L. Baldwin, MD – University of North Carolina Hospitals
5: Q&A

Xavier L. Baldwin, MD – University of North Carolina Hospitals ### 1186260###Abstract Presenter###Resident###University of North Carolina Hospitals###
Abstract Presenter: Xavier L. Baldwin, MD – University of North Carolina Hospitals
50: Q&A

Adrienne B. Shannon, MD – Hospital of the University of Pennsylvania ### 1184677###Abstract Presenter###Surgical Resident, Postdoctoral Researcher###Hospital of the University of Pennsylvania###
Abstract Presenter: Adrienne B. Shannon, MD – Hospital of the University of Pennsylvania
50: Sentinel Lymph Node Biopsy in Patients with t1a Cutaneous Malignant Melanoma

Adrienne B. Shannon, MD – Hospital of the University of Pennsylvania ### 1184677###Abstract Presenter###Surgical Resident, Postdoctoral Researcher###Hospital of the University of Pennsylvania###
Abstract Presenter: Adrienne B. Shannon, MD – Hospital of the University of Pennsylvania
51: Q&A

Aaron D. Therien, MS, BS – Duke University Medical Center ### 1530231###Abstract Presenter###Research Technician II###Duke University Medical Center###
Abstract Presenter: Aaron D. Therien, MS, BS – Duke University Medical Center
51: Spatial Biology Analysis Reveals the Location and Activation of B Cells in Sentinel Lymph Nodes Correlate with Prognosis in Melanoma Patients

Aaron D. Therien, MS, BS – Duke University Medical Center ### 1530231###Abstract Presenter###Research Technician II###Duke University Medical Center###
Abstract Presenter: Aaron D. Therien, MS, BS – Duke University Medical Center
52: Q&A

Zachary J. Senders, MD – University of Louisville ### 1530282###Abstract Presenter###Surgical Oncology Fellow###University of Louisville###
Abstract Presenter: Zachary J. Senders, MD – University of Louisville
52: Stage Migration as a Consequence of Omitting Completion Lymph Node Dissection for Melanoma

Zachary J. Senders, MD – University of Louisville ### 1530282###Abstract Presenter###Surgical Oncology Fellow###University of Louisville###
Abstract Presenter: Zachary J. Senders, MD – University of Louisville
53: Q&A

Jared Theriot, MD – Memorial Sloan Kettering Cancer Center ### 970123###Abstract Presenter###Research Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Jared Theriot, MD – Memorial Sloan Kettering Cancer Center
53: T-VEC Treatment Reverses PD-1 Resistance by Altering the Microenvironment of Tumors

Jared Theriot, MD – Memorial Sloan Kettering Cancer Center ### 970123###Abstract Presenter###Research Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Jared Theriot, MD – Memorial Sloan Kettering Cancer Center
54: Diversity, Equity and Inclusion in Surgical Oncology Societies: A Membership Perspective

Martha E. Teke, MD – National Cancer Institute - National Institute of Health ### 1530313###Abstract Presenter###Clinical Research Fellow###National Cancer Institute - National Institute of Health###
Abstract Presenter: Martha E. Teke, MD – National Cancer Institute - National Institute of Health
54: Q&A

Martha E. Teke, MD – National Cancer Institute - National Institute of Health ### 1530313###Abstract Presenter###Clinical Research Fellow###National Cancer Institute - National Institute of Health###
Abstract Presenter: Martha E. Teke, MD – National Cancer Institute - National Institute of Health
55: A Perioperative Bundle for Reduction of Incisional Surgical Site Infections Following Pancreaticoduodenectomy: A Pre-post Intervention Study

Thomas L. Sutton, MD – Oregon Health and Science University ### 1186045###Abstract Presenter###Resident###Oregon Health and Science University###
Abstract Presenter: Thomas L. Sutton, MD – Oregon Health and Science University
55: Q&A

Thomas L. Sutton, MD – Oregon Health and Science University ### 1186045###Abstract Presenter###Resident###Oregon Health and Science University###
Abstract Presenter: Thomas L. Sutton, MD – Oregon Health and Science University
56: Combined Impact of Race, Neighborhood, and Dual Eligibility with Mortality After Cancer Surgery Among Medicare Beneficiaries

Sidra Bonner, MD MPH – University of Michigan ### 1530286###Abstract Presenter###General Surgery Resident###University of Michigan###
Abstract Presenter: Sidra Bonner, MD MPH – University of Michigan
56: Q&A

Sidra Bonner, MD MPH – University of Michigan ### 1530286###Abstract Presenter###General Surgery Resident###University of Michigan###
Abstract Presenter: Sidra Bonner, MD MPH – University of Michigan
57: Differences in Experiences with Cancer Survivorship Follow-up Among Cancer Survivors in Canada Based on Physician Specialty

Megan Delisle, MD MPH – University of Ottawa ### 1530229###Abstract Presenter###Complex General Surgical Oncology Fellow ###University of Ottawa###
Abstract Presenter: Megan Delisle, MD MPH – University of Ottawa
57: Q&A

Megan Delisle, MD MPH – University of Ottawa ### 1530229###Abstract Presenter###Complex General Surgical Oncology Fellow ###University of Ottawa###
Abstract Presenter: Megan Delisle, MD MPH – University of Ottawa
58: How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Moderate-severe Pain Following Mastectomy

Linda Pak, MD – Memorial Sloan Kettering Cancer Center ### 1530272###Abstract Presenter###Breast Surgery Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Linda Pak, MD – Memorial Sloan Kettering Cancer Center
58: Q&A

Linda Pak, MD – Memorial Sloan Kettering Cancer Center ### 1530272###Abstract Presenter###Breast Surgery Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Linda Pak, MD – Memorial Sloan Kettering Cancer Center
59: Overcoming Barriers to Implementation of Gastric Cancer Surgical Standards Through Tumor Board Engagement: Stakeholder Input

Shivani Mehta, MD Candidate – UC San Diego School of Medicine ### 1534599###Abstract Presenter###Medical Student###UC San Diego School of Medicine ###
Abstract Presenter: Shivani Mehta, MD Candidate – UC San Diego School of Medicine
59: Q&A

Shivani Mehta, MD Candidate – UC San Diego School of Medicine ### 1534599###Abstract Presenter###Medical Student###UC San Diego School of Medicine ###
Abstract Presenter: Shivani Mehta, MD Candidate – UC San Diego School of Medicine
6: BREAST-Q Scores 10 Years After Breast-conserving Surgery for Early-stage Breast Cancer

Laura Dominici, MD – Dana Farber, Brigham and Women's Cancer Center ### 970141###Abstract Presenter###Associate Surgeon###Dana Farber, Brigham and Women's Cancer Center###
Abstract Presenter: Laura Dominici, MD – Dana Farber, Brigham and Women's Cancer Center
6: Q&A

Laura Dominici, MD – Dana Farber, Brigham and Women's Cancer Center ### 970141###Abstract Presenter###Associate Surgeon###Dana Farber, Brigham and Women's Cancer Center###
Abstract Presenter: Laura Dominici, MD – Dana Farber, Brigham and Women's Cancer Center
60: Q&A

Kevin M. Sullivan, MD – City of Hope ### 1530274###Abstract Presenter###Fellow###City of Hope###
Abstract Presenter: Kevin M. Sullivan, MD – City of Hope
60: The Hidden Costs of Medicare Advantage: Association with Limited Access to High-volume Complex Cancer Surgery and Detriment in Long-term Survival

Kevin M. Sullivan, MD – City of Hope ### 1530274###Abstract Presenter###Fellow###City of Hope###
Abstract Presenter: Kevin M. Sullivan, MD – City of Hope
61: Q&A

Ankit Dhiman, MBBS, MS – Department of Surgery, University of Chicago, Chicago, IL ### 1530332###Abstract Presenter###Postdoctoral Scholar###Department of Surgery, University of Chicago, Chicago, IL###
Abstract Presenter: Ankit Dhiman, MBBS, MS – Department of Surgery, University of Chicago, Chicago, IL
61: Role of Tumor-informed Personalized Ctdna Assay in Informing Recurrence in Patients with Peritoneal Metastases from Colorectal and High-grade Appendix Cancer Undergoing Curative Surgery

Ankit Dhiman, MBBS, MS – Department of Surgery, University of Chicago, Chicago, IL ### 1530332###Abstract Presenter###Postdoctoral Scholar###Department of Surgery, University of Chicago, Chicago, IL###
Abstract Presenter: Ankit Dhiman, MBBS, MS – Department of Surgery, University of Chicago, Chicago, IL
62: Intratumoral Injection of the Toll-like Receptor 4 Agonist G100 Induces Durable Local Control and Causes Immune Activation in the Tumor Microenvironment in Metastatic Soft Tissue Sarcomas

Yongwoo D. Seo, MD – MD Anderson Cancer Center ### 1530240###Abstract Presenter###Fellow###MD Anderson Cancer Center###
Abstract Presenter: Yongwoo D. Seo, MD – MD Anderson Cancer Center
62: Q&A

Yongwoo D. Seo, MD – MD Anderson Cancer Center ### 1530240###Abstract Presenter###Fellow###MD Anderson Cancer Center###
Abstract Presenter: Yongwoo D. Seo, MD – MD Anderson Cancer Center
63: Novel Double-loaded Implantable Paclitaxel-eluting Polymer (Pax-film) to Prevent of Locoregional Recurrence After Resection of Retroperitoneal Sarcoma (RPS)

Mehida Rojas-Alexandre, MD – Brigham and Women's Hospital ### 1530308###Abstract Presenter###General Surgery Resident###Brigham and Women's Hospital###
Abstract Presenter: Mehida Rojas-Alexandre, MD – Brigham and Women's Hospital
63: Q&A

Mehida Rojas-Alexandre, MD – Brigham and Women's Hospital ### 1530308###Abstract Presenter###General Surgery Resident###Brigham and Women's Hospital###
Abstract Presenter: Mehida Rojas-Alexandre, MD – Brigham and Women's Hospital
64: Q&A

Andrew Tieniber, MD – University of Pennsylvania ### 1530270###Abstract Presenter###General Surgery Resident ###University of Pennsylvania###
Abstract Presenter: Andrew Tieniber, MD – University of Pennsylvania
64: Single-cell RNA Sequencing Reveals Differential Tumor Cell Response to Imatinib in Gastrointestinal Stromal Tumor

Andrew Tieniber, MD – University of Pennsylvania ### 1530270###Abstract Presenter###General Surgery Resident ###University of Pennsylvania###
Abstract Presenter: Andrew Tieniber, MD – University of Pennsylvania
65: Disparate Survival for Colorectal Cancer in Rural vs Urban Populations Is Not Explained by Lack of Receipt of Guideline-concordant Therapy

Tyler J. Mouw, MD – University of Louisville ### 1530317###Abstract Presenter###Fellow###University of Louisville###
Abstract Presenter: Tyler J. Mouw, MD – University of Louisville
65: Q&A

Tyler J. Mouw, MD – University of Louisville ### 1530317###Abstract Presenter###Fellow###University of Louisville###
Abstract Presenter: Tyler J. Mouw, MD – University of Louisville
66: Disparities in Care Access to Liver-directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis

Christopher T. Aquina, MD, MPH – AdventHealth Orlando ### 1530277###Abstract Presenter###Colon and Rectal Surgery Fellow###AdventHealth Orlando###
Abstract Presenter: Christopher T. Aquina, MD, MPH – AdventHealth Orlando
66: Q&A

Christopher T. Aquina, MD, MPH – AdventHealth Orlando ### 1530277###Abstract Presenter###Colon and Rectal Surgery Fellow###AdventHealth Orlando###
Abstract Presenter: Christopher T. Aquina, MD, MPH – AdventHealth Orlando
67: Bilateral Robotic-assisted Nipple-sparing Mastectomy Using a Single Incision

Daniel B. Hewitt, MD, MPH, MS – The Ohio State University Medical Center - Columbus, OH ### 1530285###Abstract Presenter###Surgical Oncology Fellow###The Ohio State University Medical Center - Columbus, OH###
Abstract Presenter: Daniel B. Hewitt, MD, MPH, MS – The Ohio State University Medical Center - Columbus, OH
67: Q&A

Daniel B. Hewitt, MD, MPH, MS – The Ohio State University Medical Center - Columbus, OH ### 1530285###Abstract Presenter###Surgical Oncology Fellow###The Ohio State University Medical Center - Columbus, OH###
Abstract Presenter: Daniel B. Hewitt, MD, MPH, MS – The Ohio State University Medical Center - Columbus, OH
68: Managing the Soft Pancreas During Robotic Pancreaticoduodenectomy: Technique for Externalized Pancreatic Stent

ALI AHMAD, MD, FACS – University of Kansas, School of Medicine-Wichita ### 1530253###Abstract Presenter###Assistant Professor of Surgery###University of Kansas, School of Medicine-Wichita###
Abstract Presenter: ALI AHMAD, MD, FACS – University of Kansas, School of Medicine-Wichita
68: Q&A

ALI AHMAD, MD, FACS – University of Kansas, School of Medicine-Wichita ### 1530253###Abstract Presenter###Assistant Professor of Surgery###University of Kansas, School of Medicine-Wichita###
Abstract Presenter: ALI AHMAD, MD, FACS – University of Kansas, School of Medicine-Wichita
69: Q&A

Vikas Satyananda, MD – Kaiser Permanente Los Angeles Medical Center ### 1530258###Abstract Presenter###Surgical Oncology ###Kaiser Permanente Los Angeles Medical Center###
Abstract Presenter: Vikas Satyananda, MD – Kaiser Permanente Los Angeles Medical Center
69: Robot Assisted Transgastric Resection of Leiomyoma at Gastroesophageal Junction

Vikas Satyananda, MD – Kaiser Permanente Los Angeles Medical Center ### 1530258###Abstract Presenter###Surgical Oncology ###Kaiser Permanente Los Angeles Medical Center###
Abstract Presenter: Vikas Satyananda, MD – Kaiser Permanente Los Angeles Medical Center
7: Factors Associated with Axillary Dissection in Breast Conserving Surgery or Mastectomy for ct1-2n0 Breast Cancer with 1-2 Positive Sentinel Lymph Node(s)

Arielle P. Stafford, MD – Mayo Clinic ### 1530288###Abstract Presenter###Breast Surgical Oncology Fellow###Mayo Clinic###
Abstract Presenter: Arielle P. Stafford, MD – Mayo Clinic
7: Q&A

Arielle P. Stafford, MD – Mayo Clinic ### 1530288###Abstract Presenter###Breast Surgical Oncology Fellow###Mayo Clinic###
Abstract Presenter: Arielle P. Stafford, MD – Mayo Clinic
70: Q&A

Joanna T. Swinarska, MD – Milton S. Hershey Medical Center ### 1530291###Abstract Presenter###General Surgery Resident###Milton S. Hershey Medical Center###
Abstract Presenter: Joanna T. Swinarska, MD – Milton S. Hershey Medical Center
70: Robotic Excision of a Type I Choledochal Cyst with Roux-en-y Hepaticojejunostomy

Joanna T. Swinarska, MD – Milton S. Hershey Medical Center ### 1530291###Abstract Presenter###General Surgery Resident###Milton S. Hershey Medical Center###
Abstract Presenter: Joanna T. Swinarska, MD – Milton S. Hershey Medical Center
71: Robotic Extended Central Hepatectomy for Intrahepatic Cholangiocarcinoma

Shlomi Rayman ### 1601222###Abstract Presenter#########
Abstract Presenter: Shlomi Rayman
71: Q&A

Iswanto Sucandy, MD FACS – AdventHealth Tampa ### 1530303###Abstract Presenter###Director, Center for Liver Cancers and Disorders###AdventHealth Tampa###
Abstract Presenter: Iswanto Sucandy, MD FACS – AdventHealth Tampa
72: Q&A

MAUTIN HUNDEYIN, MD – MEMORIAL SLOAN KETTERING CANCER CENTER ### 1530202###Abstract Presenter###FELLOW###MEMORIAL SLOAN KETTERING CANCER CENTER###
Abstract Presenter: MAUTIN HUNDEYIN, MD – MEMORIAL SLOAN KETTERING CANCER CENTER
72: Robotic Proximal Gastrectomy with Double Tract Reconstruction for Locally Advanced Siewert II Gastroesophageal junction Cancer

MAUTIN HUNDEYIN, MD – MEMORIAL SLOAN KETTERING CANCER CENTER ### 1530202###Abstract Presenter###FELLOW###MEMORIAL SLOAN KETTERING CANCER CENTER###
Abstract Presenter: MAUTIN HUNDEYIN, MD – MEMORIAL SLOAN KETTERING CANCER CENTER
73: Q&A

Amr I. Al Abbas, MD – UT Southwestern Medical Center ### 1530336###Abstract Presenter###Resident###UT Southwestern Medical Center###
Abstract Presenter: Amr I. Al Abbas, MD – UT Southwestern Medical Center
73: Robotic Transduodenal Ampullectomy for Ampullary Adenoma

Amr I. Al Abbas, MD – UT Southwestern Medical Center ### 1530336###Abstract Presenter###Resident###UT Southwestern Medical Center###
Abstract Presenter: Amr I. Al Abbas, MD – UT Southwestern Medical Center
74: Q&A

Iswanto Sucandy, MD FACS – AdventHealth Tampa ### 1530303###Abstract Presenter###Director, Center for Liver Cancers and Disorders###AdventHealth Tampa###
Abstract Presenter: Iswanto Sucandy, MD FACS – AdventHealth Tampa
74: Techniques and Outcomes of Robotic Resection for Perihilar & Extrahepatic Cholangiocarcinoma Requiring Biliary Reconstruction

Iswanto Sucandy, MD FACS – AdventHealth Tampa ### 1530303###Abstract Presenter###Director, Center for Liver Cancers and Disorders###AdventHealth Tampa###
Abstract Presenter: Iswanto Sucandy, MD FACS – AdventHealth Tampa
75: Using an ex-vivo Human Tumor Platform to Perform Dynamic Live Tumor Imaging

Areeba Saif, MD – National Institutes of Health ### 1530306###Abstract Presenter###Surgical Oncology Research Fellow ###National Institutes of Health###
Abstract Presenter: Areeba Saif, MD – National Institutes of Health
75: Q&A

Areeba Saif, MD – National Institutes of Health ### 1530306###Abstract Presenter###Surgical Oncology Research Fellow ###National Institutes of Health###
Abstract Presenter: Areeba Saif, MD – National Institutes of Health
76: A Unique Immunosuppressive Macrophage Transcriptional Signature Is a Poor Prognostic Biomarker in Primary Upper GI Cancer

Kevin M. Sullivan, MD – City of Hope ### 1530274###Abstract Presenter###Fellow###City of Hope###
Abstract Presenter: Kevin M. Sullivan, MD – City of Hope
76: Q&A

Kevin M. Sullivan, MD – City of Hope ### 1530274###Abstract Presenter###Fellow###City of Hope###
Abstract Presenter: Kevin M. Sullivan, MD – City of Hope
77: Gastric Cancer with Enhanced Apical Junction Pathway Score Has Increased Metastatic Potential and Worse Clinical Outcomes

Hideo Takahashi, MD – Mount Sinai South Nassau ### 1530208###Abstract Presenter###Surgical Oncology###Mount Sinai South Nassau###
Abstract Presenter: Hideo Takahashi, MD – Mount Sinai South Nassau
77: Q&A

Hideo Takahashi, MD – Mount Sinai South Nassau ### 1530208###Abstract Presenter###Surgical Oncology###Mount Sinai South Nassau###
Abstract Presenter: Hideo Takahashi, MD – Mount Sinai South Nassau
78: Is Gastrointestinal Stromal Tumor Progression Mediated by Class I Downregulation?

Andrew Hanna, MD – University of Pennsylvania ### 1184656###Abstract Presenter###Resident###University of Pennsylvania###
Abstract Presenter: Andrew Hanna, MD – University of Pennsylvania
78: Q&A

Andrew Hanna, MD – University of Pennsylvania ### 1184656###Abstract Presenter###Resident###University of Pennsylvania###
Abstract Presenter: Andrew Hanna, MD – University of Pennsylvania
79: Loss of Tumor Suppressor FAM46C Induces Ion Channelopathy in Gastric Adenocarcinoma

Karineh Kazazian, MD PhD FRCSC – University of Toronto ### 1593050###Abstract Presenter###Fellow###University of Toronto###
Abstract Presenter: Karineh Kazazian, MD PhD FRCSC – University of Toronto
79: Q&A

Karineh Kazazian, MD PhD FRCSC – University of Toronto ### 1593050###Abstract Presenter###Fellow###University of Toronto###
Abstract Presenter: Karineh Kazazian, MD PhD FRCSC – University of Toronto
8: Impact of Endocrine Therapy Adherence on Locoregional Recurrence (LRR) After Lumpectomy Without Radiotherapy in Older Women

Regina Matar, MD – Memorial Sloan Kettering Cancer Center ### 1186040###Abstract Presenter###Clinical Research Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Regina Matar, MD – Memorial Sloan Kettering Cancer Center
8: Q&A

Regina Matar, MD – Memorial Sloan Kettering Cancer Center ### 1186040###Abstract Presenter###Clinical Research Fellow###Memorial Sloan Kettering Cancer Center###
Abstract Presenter: Regina Matar, MD – Memorial Sloan Kettering Cancer Center
80: Patterns and Impact of Fractured Care on Outcomes in Stage II and III Gastric Cancer

Kristen E. Rhodin, MD – Duke University Medical Center ### 1530206###Abstract Presenter###General Surgery Resident###Duke University Medical Center###
Abstract Presenter: Kristen E. Rhodin, MD – Duke University Medical Center
80: Q&A

Kristen E. Rhodin, MD – Duke University Medical Center ### 1530206###Abstract Presenter###General Surgery Resident###Duke University Medical Center###
Abstract Presenter: Kristen E. Rhodin, MD – Duke University Medical Center
81: Postoperative Complications After Esophagectomy in CALGB 80803 (Alliance) Impact Both Short and Long-term Outcomes

Michael O. Meyers, MD, FACS – University of North Carolina at Chapel Hill ### 1048236###Abstract Presenter###Professor of Surgery###University of North Carolina at Chapel Hill###
Abstract Presenter: Michael O. Meyers, MD, FACS – University of North Carolina at Chapel Hill
81: Q&A

Michael O. Meyers, MD, FACS – University of North Carolina at Chapel Hill ### 1048236###Abstract Presenter###Professor of Surgery###University of North Carolina at Chapel Hill###
Abstract Presenter: Michael O. Meyers, MD, FACS – University of North Carolina at Chapel Hill
82: Q&A

Sam Yoon, MD – Columbia University Irving Medical Center ### 1530319###Abstract Presenter###Chief, Division of Surgical Oncology###Columbia University Irving Medical Center###
Abstract Presenter: Sam Yoon, MD – Columbia University Irving Medical Center
82: Tumor-derived Organoids from Patients with Locally Advanced Gastric Adenocarcinoma Can Predict Resistance to Neoadjuvant Chemotherapy

Sam Yoon, MD – Columbia University Irving Medical Center ### 1530319###Abstract Presenter###Chief, Division of Surgical Oncology###Columbia University Irving Medical Center###
Abstract Presenter: Sam Yoon, MD – Columbia University Irving Medical Center
83: Q&A

John J Newland, MD – University of Maryland Medical Center ### 1530215###Abstract Presenter###General Surgery Resident###University of Maryland Medical Center###
Abstract Presenter: John J Newland, MD – University of Maryland Medical Center
83: Utilization and Outcomes of Endoscopic Local Excision for Early-stage Gastric Cancers in the United States

John J Newland, MD – University of Maryland Medical Center ### 1530215###Abstract Presenter###General Surgery Resident###University of Maryland Medical Center###
Abstract Presenter: John J Newland, MD – University of Maryland Medical Center
9: Inflammatory Breast Cancer: durable Breast Cancer-specific Survival for HER2+ Patients with a Pathologic Complete Response to Neoadjuvant Therapy

Tina J. Hieken, MD – Mayo Clinic ### 937357###Abstract Presenter###Professor of Surgery###Mayo Clinic###
Abstract Presenter: Tina J. Hieken, MD – Mayo Clinic
9: Q&A

Tina J. Hieken, MD – Mayo Clinic ### 937357###Abstract Presenter###Professor of Surgery###Mayo Clinic###
Abstract Presenter: Tina J. Hieken, MD – Mayo Clinic